1 of 1
Story summary
- U.S. President Donald Trump announced suspending the de minimis exemption for prescription drug shipments, effective Oct. 22.
- The rule ends duty-free entry for shipments under $800 and adds documentation, tariffs, and FDA checks.
- Up to 4 million Americans, especially seniors, could lose 52%-89% savings and face $500-$1,000 higher monthly drug costs.
- More than 70 Democrats and three Florida Republicans wrote letters urging a pause over access risks.
